Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
5
EVAX Quote, Financials, Valuation and Earnings
Last price:
$0.89
Seasonality move
:
-43.46%
Day range:
$0.88 - $0.96
52-week range:
$0.85 - $13.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.27x
P/B ratio:
72.85x
Volume:
73.1K
Avg. volume:
77K
1-year change:
-86.18%
Market cap:
$5.4M
Revenue:
$73K
EPS (TTM):
-$2.80
Earnings Data
Next earnings date for EVAX
Mar 27
2025
Most recent earnings per share
-$0.40
Missed by $0.28
(Oct 31/2024)
Consensus Estimate
-$0.12
(Oct 31/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
EVAX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/27/2025 | Q4 | $1.7M | -- | -- | -$0.03 | -- |
| 10/31/2024 | Q3 | -- | $3M | -$0.40 | -$0.12 | -$0.28 |
| 08/14/2024 | Q2 | $52K | $154K | -$1.20 | -$0.70 | -$0.50 |
| 05/28/2024 | Q1 | -- | $51K | $0.30 | -$0.99 | $1.29 |
| 03/27/2024 | Q4 | -- | $73K | -$1.50 | -$1.60 | $0.10 |
| 12/19/2023 | Q3 | -- | -- | -$2.10 | -$1.95 | -$0.15 |
| 08/18/2023 | Q2 | -- | -- | -$2.10 | -$2.15 | $0.05 |
| 05/31/2023 | Q1 | -- | -- | -$2.40 | -$2.40 | -- |
| 03/22/2023 | Q4 | -- | -- | -$2.90 | -$2.63 | -$0.27 |
| 11/14/2022 | Q3 | -- | -- | -$2.40 | -$2.67 | $0.27 |
| 08/10/2022 | Q2 | -- | -- | -$2.00 | -- | -- |
| 05/11/2022 | Q1 | -- | -- | -$2.50 | -- | -- |
| 03/22/2022 | Q4 | -- | -- | -$3.90 | -- | -- |
| 11/09/2021 | Q3 | -- | -- | -$2.70 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$3.60 | -- | -- |
| 05/13/2021 | Q1 | -- | -- | -$2.30 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$2.64 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$2.48 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$1.90 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$1.61 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$1.83 | -- | -- |
Evaxion Biotech AS Earnings Questions
-
How Much did Evaxion Biotech AS Generate in Revenue Last Quarter?
Evaxion Biotech AS reported $3M worth of top line sales in its most recent quarter.
-
Did Evaxion Biotech AS Beat Earnings Last Quarter?
Evaxion Biotech AS announced earnings per share of -$0.40 which represents a miss of analyst forecast a -$0.12 per share.
-
Is Evaxion Biotech AS Profitable?
Evaxion Biotech AS reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Evaxion Biotech AS EPS Next Year?
Evaxion Biotech AS's earnings are forecast to decrease from -$8.10 per share to -$7.73 per share next year representing a decrease of -98.03%.
-
When is Evaxion Biotech AS's Earnings Date?
Evaxion Biotech AS's next earnings date is March 27, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 3.14% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 5% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 2.61% over the past day.
